Score Breakdown
Below average.
Core Scientific is a high-risk, high-reward bet on successfully converting Bitcoin mining infrastructure into enterprise-grade AI data centers. The CoreWeave contract provides a credible revenue runway (~$8B+ lifetime), and management has demonstrated construction execution capability (350 MW energized). However, the stock is extremely difficult to own today: revenue is contracting in the transition trough, FCF is deeply negative, 59% dilution overhang from warrants/converts threatens per-share economics, the company has a material weakness in internal controls requiring restatement, short interest is 25%, insider selling is notable, and customer concentration is essentially 100% CoreWeave for HPC. The merger uncertainty with CoreWeave adds another layer of binary risk. Even in a bull case where the full pipeline materializes, the dilution and capital intensity substantially cap per-share upside from current levels. The risk/reward is asymmetric to the downside at $18+ given execution risks and the massive share count expansion ahead.
Negative cash flow. Can't value it.
Major red flags in SEC filings.
Shares melting fast.
Execs cashing out.
Clock is ticking.
Heavy bearish bets.
Decent.
🐻 Why Bears Hate It
The bear case centers on the 'lose-lose' scenario regarding the CoreWeave merger. If the deal closes at the current terms, shareholders are locked into a price activists argue is far below peer valuations; if it fails, analysts warn that 'weak operating results and restructuring risk' could cause the stock to plummet (YouTube/StockInvest, Sept 2025). Furthermore, short interest remains dangerously high at over 20%, reflecting skepticism toward the company's ability to pivot from low-margin Bitcoin mining to high-capital-intensity HPC services while revenue is currently contracting.
🔍 What's In The SEC Filings
The company faces a precarious balance between a massive 8-billion-dollar colocation backlog and the reality of a material restatement, deep negative equity, and an impending 60-percent share dilution.
Material Restatement of Previously Issued Financial Statements
“property, plant and equipment was overstated as a result of the improper continued capitalization of carrying values of assets committed to demolition”
The company failed to recognize impairment charges for assets slated for destruction during AI facility conversions, necessitating a restatement of the 10-K for 2024 and multiple 2025 10-Qs.
Extreme Dilution Overhang from Post-Emergence Warrants
“Total shares issuable from potentially dilutive securities 186,264 [in thousands]”
With 314M shares outstanding, the 186M in potentially dilutive securities (primarily Tranche 1 warrants and convertible notes) represents an approximate 59% dilution threat to current shareholders.
Persistent Stockholders Deficit and Negative Equity
“Total Stockholders Deficit: (-$962,740) [in thousands]”
Despite emerging from bankruptcy, the company carries an accumulated deficit of over $4.1 billion, leaving it with a massive equity hole where liabilities exceed assets by nearly $1 billion.
Significant Insider 10b5-1 Selling Plans Adopted
“Todd DuChene... Adopted Rule 10b5-1 520,000 [shares]... Matthew Brown... Adopted Rule 10b5-1 200,000 [shares]”
Key executives, including the Chief Legal Officer and COO, adopted selling plans for 780,000 shares total in late 2025, just as the colocation pivot began to materialize.
The intrinsic value must be heavily discounted for the warrant overhang and the $1 billion equity deficit. Investors should price CORZ as a venture-stage AI infrastructure play rather than an established miner, given the total reliance on uncommenced lease contracts.
The colocation segment revenue is dangerously concentrated with a single customer (Customer J at 100%), and the company faces ongoing patent infringement litigation with a trial date set for 2027.
At the current burn rate, this company will need to raise money or die.